##
##
|MESSAGE FROM THE CHAIR|AND CHIEF EXECUTIVE||
|---|---|---|
|WHO WE ARE|||
|ALLERGY IN THE UK|||
|OUR VISION AND MISSION|||
|OUR VALUES|||
|FUNDRAISING
SUPERSTARS|||
|SERVICESTO SUPPORT THE|ALLERGIC COMMUNITY|10|
|CAMPAIGNS
AND COMMUNICATIONS||16|
|ONLINE REACH||19|
|COLLABORATIONS
AND LOBBYING||20|
|CLINICAL AND RESEARCH||21|
|CONNECTIONS
AND INFLUENCE||24|
|CORPORATE PARTNERS||29|
|STRUCTURE, GOVERNANCE|AND MANAGEMENT|30|
|CHALLENGES AND RISKS||32|
|FINANCIAL REVIEW||34|
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
||||Unrestricted|Designated|Restricted|Total|Total|
|---|---|---|---|---|---|---|---|
||||Funds|Funds|Funds|2021|2020|
|||Notes||||||
|Income||||||||
|Donations
and Legacies|||199,425||73,809|273,234|44,674|
|Other Government
Grants|||85,595|||85.595||
|Income From charitable|activities||9,620|||9,620|20,226|
|Income From trading activities:||||||||
|Seal oFapproval|||338,326|||338,326|510,895|
|Renewals|||621,303|||621,303|589,589|
|Allergy Friendly Products|||61,525|||61,525|62,950|
|Agergy Awareness|Scheme||(117)|||(117)|4,850|
|Alerts|||4,325|||4,325|2,608|
|Corporate partners|||285,392||51,800|337,192|285,116|
|Fundraising
events|||19,453|||19,453|38,341|
|Investment
Income|||8,770|||8,770|6,262|
|Total Incomin
Resources||8|1,633,617||125,609|1,759,226|1,565,512|
|EXPENDITURE||||||||
|Cost oFraising Funds:||||||||
|Voluntary
income|||157,954|5,263||163,217|241,757|
|Commercial
trading|operations||495,175|||495,175|826,900|
|Expenditure
on charitable activities|||564,005|156,531|49,290|769,826|830,715|
|Total resources ex ended|||1,217,134|161,794|49,290|1,428,218|1,899,372|
|Net income l(expenditure)||||||||
|Forthe year||10|416,483|(161,794)|76,319|331,008|(333,860)|
|Reconciliation ofFunds||||||||
|Total funds brought
Forward|||91,665|737,095|9,600|838,360|1,172,220|
|Transfer between
Funds||21|(219,146)|219,146||||
|Tot
Ifunds carried
orwar|||289,002|794,447|85,919|1,169,368|838,360|
##
||||||2021||2020||
|---|---|---|---|---|---|---|---|---|
|||||Notes|E||||
|Fixed Assets|||||||||
|Intangible|Assets|||15||126,851||145,755|
|Tangible Assets||||15||22,695||30,260|
|Investments||||16||12||12|
|||||||149,558||176,027|
|Current Assets|||||||||
|Debtors||||17|252,335||420,274||
|Short Term|Investments|||18|853,098||652,852||
|Stock|||||600||||
|Cash at Bank and in Hand|||||515,702||234,033||
||||||1,621,735||1,307,159||
|Creditors:||Amounts|Falling due||||||
|within one year||||19|601,925||644,826||
|Net Current|Assets|||||1,019,810||662,333|
|Total Assets||Less Current Liabilities||||1,169,368||838,360|
|Net assets||||||1,169,368||838,360|
|Funds|||||||||
|Restricted||||20||85,919||9,600|
|Unrestricted||||21||1,083,450||828,760|
|Total funds||||||1,169,368||838,360|
##
|||Notes|Group||
|---|---|---|---|---|
||||2021|2020|
|Cash inAow/(outAow)
from operating
activities||24|473,146|(82,671)|
|Cash inAow From investing
activities|||||
|Interest income|||8,770|6,262|
|Cash used in investing
activities|||||
|Purchase ofAxed assets||||(38,311)|
|Increase in term deposit accounts|||(200,246)|(52,852)|
|Net cash (outAows) from investing
activites|||(191,476)|(84,901)|
|Increase/(decrease)
in cash and cash equivalents|in the year||281,670|(167,572)|
|Cash and cash equivalents
at 1 April 2020|||234,033|401,605|
|Total cash and cash equivalents
at 31March 2021|||515,702|234,033|
|Cash and cash equivalents
consists oF:|||||
|Cash at bank and in hand|||515,702|234,033|
|Cash and cash equivalents
at31March 2021|||515,702|234,033|
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
|The consolidated
statement of|The consolidated
statement of|The consolidated
statement of|Financial activities includes the results oFAllergy Research Limited|Financial activities includes the results oFAllergy Research Limited|Financial activities includes the results oFAllergy Research Limited|one ofthe|Charity's|wholly|
|---|---|---|---|---|---|---|---|---|
|owned subsidiaries||which operates the trade activities oFthe group including|||the Seal oFApproval,|training,|Allergy Aware Scheme||
|and an allergy alert||service.|||||||
|The summary|Financial performance|||oFthe Charity alone is:|||||
|||||||2021||2020|
|Income||||||396,641||109,251|
|Service charge From||asubsidiary|company|||300,000||300,000|
|GiFt aid from|a subsidiary
company|||||851,332||660,713|
|||||||1,547,973||1,069,964|
|Expenditure|on Fund raising|||||86,932||52,764|
|Expenditure|on trading|||||228,808||355,952|
|Expenditure|on charitable activities|||||739,430||862,241|
|||||||1,055,171||1,270,957|
|Net income||||||492,802||(200,993)|
|Total Funds brought||Forward||||950,046||1,151,039|
|Total Funds|carried|Forward||||1,442,848||950,046|
|Income From donation
and legacies|||||||||
|||||||2021||2020|
|Gifts||||||108,234||44,674|
|Legacies||||||165,000|||
|||||||273,234||44,674|
##
##
||||||2021|2020|
|---|---|---|---|---|---|---|
|Government|Grants - Coronavirus Job Retention Scheme||||85,595||
||||||85,595||
|The income From government|||grants was E85,595unrestricted|(2020:Enil) and|Enil restricted (2020:Enil).||
|Income From charitable||activities|||||
||||||2021|2020|
|Income from|translation|cards|||326|19,230|
|Fees received|||||9,294|92|
|AFI1(late marketing||||||904|
||||||9,620|20,226|
##
##
##
|||2021|2020|
|---|---|---|---|
|Turnover||1,362,554|1,456,008|
|Cost ofsales and administration|costs|(511,253)|(795,548)|
|Interest income||31|253|
|Net profit||851,332|660,713|
|Amount gift aided to the charity||(851,332)|(660,713)|
|Retained
in subsidiary||||
|The assets and liabilities oFthe|subsidiary were:|||
|Fixed assets||3,695|4,467|
|Current assets||614,987|566,463|
|Current liabilities||(597,497)|(549,747)|
|Total net assets||21,186|21,183|
|Share capital||||
|ProFit and loss reserve||21,184|21,181|
|||21,186|21,183|
##
##
##
|Turnover|||||
|---|---|---|---|---|
||||2021|2020|
|Turnover|split|geographically:|||
|||United Kingdom|936,876|565,389|
|||The Rest ofthe World|813,580|991,123|
||||1,750,456|1,556,512|
##
##
|||||||||||2021|2020|
|---|---|---|---|---|---|---|---|---|---|---|---|
||This is stated after charging:|||||||||E|E|
||Operating|leases - office||||||||71,214|75,738|
||Operating|leases -equipment||||||||10,560|9,789|
||Auditors fees|||||||||10,350|11.794|
|11.|Analysis ofstaff costs,|||Trustees expenses and the|||costofkey management|personnel||||
|||||||||||2021|2020|
|||||||||||E|E|
||Salaries and wages|||||||||633,171|757,939|
||Redundancy|costs||||||||18,032||
||Social security costs|||||||||58,144|69,584|
||Pension costs|||||||||19,267|23,627|
||Number oF|employees'||with emoluments,||as defined|For tax purposes, that amounted||to|over E60,000 in|the year.|
|||||||||||2021|2020|
||E70,000to|F79,999||||||||1||
||E60,000to|E69,999||||||||1||
||The average monthly||head count was 23|||stafF(2020|= 28)and the average number||oFFull time equivalent||employees|
||(FTE)during|the year|were as follows:|||||||||
|||||||||||2021|2020|
|||||||||||Number|Number|
|||Charitable|||activities|||||13|15|
|||Generating|||funds|||||6|9|
##
##
##
##
|||||||2021|2020|
|---|---|---|---|---|---|---|---|
|Fees|payable|to the charity's|auditors|for the audit oFthe charity's|annual accounts|6,135|6,392|
|Fees|payable|to the charity's|auditors|Forother services:||||
|||Audit oFthe charity's subsidiaries||||4,215|2,901|
|||Other services|||||2,500|
|||||||10,350|11,794|
##
##
##
|Intangib|le
Axed assets|||||||
|---|---|---|---|---|---|---|---|
|||||Group||Charity||
|||||2021|2020|2021|2020|
|||||||E|f.|
||Website and development||costs|||||
||Cost|||||||
||At 1 April 2020|||233,905|215,072|229,349|210,516|
||Additions||||18,833||18,833|
||Disposals|||||||
||At 31March 2021|||233,905|233,905|229,349|229,349|
||Amortisation|||||||
||At 1 April 2020|||88,150|63,647|86,797|62,749|
||Charge Forthe year|||18,904|24,503|18,449|24,048|
||On disposals|||||||
||At 31March 2021|||107,055|88,150|105,245|86,797|
||Net book value|||||||
||At 31 March 2021|||126,850|145,755|124,104|142,552|
||At 31March 2020|||145,755|151,425|142,552|147,767|
|Tangible|Fixed assets|||||||
|||||Group||Charity||
|||||2021|2020|2021|2020|
||||||f.||f.|
||0%ceFurniture|and equipment||||||
||Cost|||||||
||At 1 April 2020|||135,574|116,095|120,517|101,038|
||Additions||||19,479||19,479|
||Disposals|||||||
||At 31 March 2021|||135,574|135,574|120,517|120,517|
||Depreciation|||||||
||At 1 April 2020|||105,313|97,910|91,521|84,482|
||Charge Forthe year|||7,565|7,403|7,249|7,039|
||On disposals|||||||
||At 31 March 2021|||112,878|105,313|98,770|91,521|
||Net book value|||||||
||At 31 March 2021|||22,695|30,261|21,747|28,996|
||At 31 March 2020|||30,260|18,185|28,996|16,556|
##
##
|21.|Unrestricted
Funds - 2020/2021|||||||
|---|---|---|---|---|---|---|---|
|||As at 1stApril
2020|Surplus/Deficit
2020/21|For|Expenditure|Transfers|As at31stMarch
2021|
|||E|E|||E|E|
||General free reserve|70,482|416,483|||(219,146)|267,819|
||Designated:|||||||
||Fixed assets reserve|28,996||||(7,250)|21,746|
||Allergy
UKnurses project|186,616|||(108,618)|(77,998)||
||CRM/Digital
Media reserve|50,000|||(43,810)|15,000|21,190|
||Contingency
Fund|466,220|||||466,220|
||Fundraising
reserve|5,263|||(5,263)|50,000|50,000|
||Board Project reserve||||(4,103)|4,103||
||Shout Out to Allergy reserve|||||50,000|50,000|
||Resource Building reserve|||||100,291|100,291|
||Project Delivery reserve|||||75,000|75,000|
||ITreserve|||||10,000|10,000|
||Total Charity Reserves|807,577|416,483||(161,794)||1,062,266|
||Allergy Research Ltd|21,183|||||21,183|
||Total Group Reserves|828,760|416,483||(161,794)||1,083,449|
|Unrestricted|Funds|—2019/2020|||||||
|---|---|---|---|---|---|---|---|---|
||||As at 1stApril
2019|Surplus/Deficit
2019/20|For|Expenditure|Transfers|As at31stMarch
2020|
||||E|E|||E|f.|
|General Free reserve|||85,227|(174,293)|||159,548|70,482|
|Designated:|||||||||
|Fixed assets|reserve||16,556||||12,440|28,996|
|Allergy
UK nurses project|||212,260|||(46,686)|21,042|186,616|
|CRM/Digital|Media reserve||200,000||||(150,000)|50,000|
|Contingency|Fund||600,694||||(134,474)|466,220|
|Fundraising|reserve|||||(86,181)|91,444|5,263|
|Total Charity|Reserves||1,114,737|(174,293)||(132,867)||807,577|
|Allergy Research Ltd|||21,183|||||21,183|
|Total Group|Reserves||1,135,920|(174,293)||(132,867)||828,760|
##
##
||As at 31M|arch 2021|||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|||General|Fixed|Contingency|Fd.
Fundraising||Shout Out
to Allergy|Resource
Suilding|project
Delivery|IT|Restricted|Total|
|||Reserves|Assets|Fund|Reserve|Reserve|Reserve|Reserve|Reserve|Reserve|Funds|Funds|
|Tangible|Fixed assets|127,812|21,746|||||||||149,558|
|Current|assets|743,350||466,220|21,190|50,000|50,000|100,291|75,000|10,000|85,919|1,601,969|
|Current|liabilities|(582,160)||||||||||(582,160)|
|Net assets at 31
March 2021||289,002|21,746|466,220|21,190|50,000|50,000|100,291|75,000|10,000|85,919|1,169,368|
##
|As at31March 202|0|||||||||
|---|---|---|---|---|---|---|---|---|---|
||General|Fixed|Contingency|Nurses|CRM|Fundraising||Restricted|Total|
||Reserves|Assets|Fund|Reserve|Reserve||Reserve|Funds|Funds|
||||E|E|E||E|E||
|Tangible fixed assets|147,031|28,996|||||||176,027|
|Current assets|589,460||466,220|186,616|50,000||5,263|9,600|1,307,159|
|Current
liabilities|(644,826)||||||||(644,826)|
|Net assets at 31
March 2020|91,665|28,996|466,220|186,616|50,000||5,263|9,600|838,360|
##
##
##